DE4006628A1 - Fabric pad such as plaster - is impregnated with materials such as anti-allergens, or for treating inflammation, itching or stings in skin - Google Patents
Fabric pad such as plaster - is impregnated with materials such as anti-allergens, or for treating inflammation, itching or stings in skinInfo
- Publication number
- DE4006628A1 DE4006628A1 DE4006628A DE4006628A DE4006628A1 DE 4006628 A1 DE4006628 A1 DE 4006628A1 DE 4006628 A DE4006628 A DE 4006628A DE 4006628 A DE4006628 A DE 4006628A DE 4006628 A1 DE4006628 A1 DE 4006628A1
- Authority
- DE
- Germany
- Prior art keywords
- skin
- plaster
- itching
- stings
- allergens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 6
- 208000003251 Pruritus Diseases 0.000 title abstract description 4
- 230000007803 itching Effects 0.000 title abstract description 3
- 239000000463 material Substances 0.000 title abstract 3
- 208000003014 Bites and Stings Diseases 0.000 title abstract 2
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 239000013566 allergen Substances 0.000 title abstract 2
- 239000004744 fabric Substances 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 4
- 230000003266 anti-allergic effect Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 230000001139 anti-pruritic effect Effects 0.000 claims description 2
- 239000003908 antipruritic agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000006748 scratching Methods 0.000 abstract description 3
- 230000002393 scratching effect Effects 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 239000000126 substance Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Die Erfindung betrifft eine neue Anwendungsmethode für sämtliche anti allergische, entzündungshemmende und juckreizstillende Hautmittel. Die bisher bekannten Medikamente gegen Juckreiz, Insektenstiche und aller gische Hautreaktionen werden entweder in Tablettenform oder in Form von sogenannten Dermatika, d. h. äußerlich auf die erkrankten Hautpartien aufzutragende Salben, Gele, Emulsionen etc. verabreicht. Die Verwendung von Tabletten führt allerdings zu einer nicht unerheblichen Belastung des gesamten Organismus. Diese Ganzkörperbelastung kann zwar vermieden werden, indem der Patient Salben, Gele, oder Emulsionen auf die erkrankte Hautpar tie aufträgt. In diesem Falle wirkt sie nur dort, wo das entsprechende Hautmedikament aufgetragen wird. Nachteilig bei diesem Verfahren ist aller dings die relativ kurze Wirkungsdauer der Substanz. Dies ist zum einen da rauf zurückzuführen, daß durch das Auftragen mit der Hand nur eine dünne Schicht des Medikaments auf der Haut verabreicht werden kann. Nach dem Auf tragen erfolgt eine Resorption der Wirkungssubstanz in den oberen Haut schichten, so daß die Wirkung nur über wenige Stunden anhält. Um dem ent gegenzuwirken, wäre eine mehrmalige tägliche Neuanwendung erforderlich. The invention relates to a new application method for all anti allergic, anti-inflammatory and antipruritic skin products. The previously known drugs for itching, insect bites and all Skin reactions are either in tablet form or in the form of so-called dermatics, d. H. externally on the diseased areas of the skin ointments, gels, emulsions, etc. to be applied. The usage of tablets, however, leads to a not inconsiderable burden on the entire organism. This whole body strain can be avoided by applying ointments, gels, or emulsions to the diseased skin par tie applies. In this case it only works where the corresponding one Skin medication is applied. This process is disadvantageous in everything dings the relatively short duration of action of the substance. On the one hand, this is there attributed to the fact that by hand application only a thin Layer of the drug can be administered on the skin. After opening wear resorbs the active substance in the upper skin layers so that the effect only lasts for a few hours. To ent to counteract this would require repeated daily use.
Gleichzeitig wird durch den Kontakt mit der Umgebung, insbesondere mit Kleidungsstücken die Wirksubstanz wieder abgetragen und es kommt insoweit zu einem Wirkungsverlust. Zu diesem Wirkungsverlust führen darüber hinaus Komponenten wie Schweißbildung, Hautreinigungen durch Waschvorgänge, oder Verunreinigungen von außen. Eine Steigerung der Wirkungskonzentration durch entsprechend dickes Auftragen ist methodisch bedingt nicht möglich. Außerdem ist der vorstehend dargelegte Wirkungsverlust in der herkömm lichen Anwendungsform auch durch Verabreichung höherer Konzentrationen nicht zu verhindern. Denn die zu behandelnde Hautregion und die entsprech enden Medikamente sind Witterungseinflüssen und möglichen chemischen Fremdeinwirkungen direkt ausgesetzt. Zudem erschwert das ständige Mitfüh ren eines Präparats für mehrfach zu wiederholende Anwendung die konsequen te Behandlung. Nicht zu unterschätzen ist darüber hinaus eine Verunreini gung von Kleidungsstücken, Bettwäsche, etc.. Darüber hinaus besteht insbe sondere bei juckenden Hauterkrankungen ein gesteigertes Kratzbedürfnis, das neben der dadurch bedingten Belästigung auch das Risiko von Hautver letzungen und Infektionen steigert.At the same time, through contact with the environment, especially with Garments the active substance removed again and it comes to that extent to a loss of effectiveness. In addition, lead to this loss of effectiveness Components such as perspiration, skin cleaning through washing processes, or Impurities from the outside. An increase in the concentration of effects due to the thick application it is not possible due to the method. In addition, the loss of effectiveness set forth above is conventional Liche application form by administration of higher concentrations unavoidable. Because the skin region to be treated and the corresponding End medications are weather influences and possible chemical Directly exposed to external influences. In addition, constant carrying along makes it difficult the consequences of a preparation for repeated use treatment. An impurity is also not to be underestimated supply of clothing, bed linen, etc. In addition, there is esp especially in the case of itchy skin diseases, an increased need for scratching, in addition to the resulting annoyance, the risk of skin ver injuries and infections.
Der Erfindung liegt die Aufgabe zugrunde, die vorstehend beschriebenen Mängel bei der herkömmlichen Anwendungsform auszuschalten und den Hei lungsprozeß durch konzentrierte Einwirkungsmöglichkeit der aufzutragenden Substanz zu verkürzen.The invention is based on the object described above Defects in the conventional form of application and the Hei development process by means of concentrated influence by those to be applied Shorten substance.
Diese Aufgabe wird erfindungsmäßig dadurch gelöst, daß die Wirksubstanz mittels eines Pflasters auf der erkrankten Hautstelle zur Anwendung ge bracht wird. Die Substanz wird entweder auf dem Vlies oder auf einen in das Pflaster eingearbeiteten Objektträger, ähnlich einer Kontaktlinse, auf getragen und mittels des Pflasters auf der erkrankten Hautstelle fixiert.This object is achieved according to the invention in that the active substance by means of a plaster on the diseased skin area for application is brought. The substance is either on the fleece or on one in the plaster incorporated slide, similar to a contact lens worn and fixed on the diseased skin area with the plaster.
Durch diese Anwendungsform wird gewährleistet, daß das anzuwendende Präpa rat in ausreichender Menge und in einem therapeutisch ausreichenden Zeit raum dargereicht werden kann. Die Substanz ist vor Austrocknung geschützt und nicht verwischbar. Zudem werden Kleidungsstücke und Gegenstände vor der Substanz geschützt. Darüber hinaus wird die Belästigung für den Pa tienten reduziert und Sekundärinfektionen durch Kratzen werden vermieden. Besonders hervorzuheben ist, daß die o. g. Hauterkrankungen durch die konzentrierte Einwirkung in wesentlich kürzerer Zeit abheilen.This form of application ensures that the preparation to be used advice in sufficient quantity and in a therapeutically sufficient time space can be presented. The substance is protected from drying out and not smudge. In addition, items of clothing and items are presented protected from the substance. In addition, the harassment for the Pa patients are reduced and secondary infections caused by scratching are avoided. It should be particularly emphasized that the above-mentioned. Skin diseases by the heal concentrated action in a much shorter time.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4006628A DE4006628A1 (en) | 1990-03-06 | 1990-03-06 | Fabric pad such as plaster - is impregnated with materials such as anti-allergens, or for treating inflammation, itching or stings in skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4006628A DE4006628A1 (en) | 1990-03-06 | 1990-03-06 | Fabric pad such as plaster - is impregnated with materials such as anti-allergens, or for treating inflammation, itching or stings in skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE4006628A1 true DE4006628A1 (en) | 1990-11-22 |
Family
ID=6401307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE4006628A Ceased DE4006628A1 (en) | 1990-03-06 | 1990-03-06 | Fabric pad such as plaster - is impregnated with materials such as anti-allergens, or for treating inflammation, itching or stings in skin |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE4006628A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE9404634U1 (en) * | 1994-03-18 | 1994-08-25 | Walter, Klaus, 83088 Kiefersfelden | Drug holder for cooling sleeves |
| DE19833177A1 (en) * | 1998-07-23 | 2000-01-27 | Labtec Gmbh | Rapidly acting plaster preparation for treating irritation due to nettle stings or insect bites, preferably containing menthol and benzocaine |
| DE10024396A1 (en) * | 2000-05-17 | 2001-11-22 | Labtec Gmbh | Plaster composition for treating insect bites or nettle stings, based on menthol and ribwort tincture and colored to make it attractive to children |
| EP1589917A2 (en) * | 2003-02-07 | 2005-11-02 | Teikoku Pharma USA, Inc. | Methods of administering a dermatological agent to a subject |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1925348B (en) * | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Plaster for the treatment of non-wet, therapy-resistant dermatoses | ||
| DE1767068A1 (en) * | 1967-03-29 | 1972-01-05 | Lilly Co Eli | Medical adhesive plaster |
| DE1931080B2 (en) * | 1969-06-10 | 1978-04-20 | Lucien Paris Nouvel | Ointment-like wound dressing |
| DE3033606A1 (en) * | 1980-09-06 | 1982-04-08 | B. Braun Melsungen Ag, 3508 Melsungen | ANTI-ADHESIVE, ANTIMICROBIAL Wound Bandage AND METHOD FOR THE PRODUCTION THEREOF |
| DE3438005A1 (en) * | 1984-10-17 | 1986-04-17 | Röhm GmbH, 6100 Darmstadt | PHARMACEUTICAL AGENT FOR LOCAL THERAPY OF PSORIASIS |
| DE3632510A1 (en) * | 1985-09-26 | 1987-04-02 | Shionogi & Co | TOPICAL ANTI-INFLAMMATORY AND ANALGETIC MEDICINAL PRODUCT |
-
1990
- 1990-03-06 DE DE4006628A patent/DE4006628A1/en not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1925348B (en) * | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Plaster for the treatment of non-wet, therapy-resistant dermatoses | ||
| DE1767068A1 (en) * | 1967-03-29 | 1972-01-05 | Lilly Co Eli | Medical adhesive plaster |
| DE1931080B2 (en) * | 1969-06-10 | 1978-04-20 | Lucien Paris Nouvel | Ointment-like wound dressing |
| DE3033606A1 (en) * | 1980-09-06 | 1982-04-08 | B. Braun Melsungen Ag, 3508 Melsungen | ANTI-ADHESIVE, ANTIMICROBIAL Wound Bandage AND METHOD FOR THE PRODUCTION THEREOF |
| DE3438005A1 (en) * | 1984-10-17 | 1986-04-17 | Röhm GmbH, 6100 Darmstadt | PHARMACEUTICAL AGENT FOR LOCAL THERAPY OF PSORIASIS |
| DE3632510A1 (en) * | 1985-09-26 | 1987-04-02 | Shionogi & Co | TOPICAL ANTI-INFLAMMATORY AND ANALGETIC MEDICINAL PRODUCT |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE9404634U1 (en) * | 1994-03-18 | 1994-08-25 | Walter, Klaus, 83088 Kiefersfelden | Drug holder for cooling sleeves |
| DE19833177A1 (en) * | 1998-07-23 | 2000-01-27 | Labtec Gmbh | Rapidly acting plaster preparation for treating irritation due to nettle stings or insect bites, preferably containing menthol and benzocaine |
| DE10024396A1 (en) * | 2000-05-17 | 2001-11-22 | Labtec Gmbh | Plaster composition for treating insect bites or nettle stings, based on menthol and ribwort tincture and colored to make it attractive to children |
| DE10024396B4 (en) * | 2000-05-17 | 2006-07-27 | Beiersdorf Ag | Plaster cover for children |
| EP1589917A2 (en) * | 2003-02-07 | 2005-11-02 | Teikoku Pharma USA, Inc. | Methods of administering a dermatological agent to a subject |
| EP1589917A4 (en) * | 2003-02-07 | 2006-03-29 | Teikoku Pharma Usa Inc | Methods of administering a dermatological agent to a subject |
| US7887842B2 (en) | 2003-02-07 | 2011-02-15 | Teikoku Pharma Usa, Inc. | Methods of administering a dermatological agent to a subject |
| US8449913B2 (en) | 2003-02-07 | 2013-05-28 | Teikoku Pharma Usa, Inc. | Methods of administering a dermatological agent to a subject |
| US9023392B2 (en) | 2003-02-07 | 2015-05-05 | Teikoku Pharma Usa, Inc. | Methods of administering a dermatological agent to a subject |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60129733T2 (en) | COMPRESSING COMPOSITE ELASTIC SUSPENDED | |
| EP0059917A1 (en) | Protective bandage for legs and joints of hoofed animals | |
| DE2260536A1 (en) | NEW SILVER CYCLOHEPTAAMYLOSE INCLUDING COMPOUND, METHOD OF MANUFACTURING AND USING IT | |
| EP1076540B1 (en) | Compression bandage | |
| DE4006628A1 (en) | Fabric pad such as plaster - is impregnated with materials such as anti-allergens, or for treating inflammation, itching or stings in skin | |
| DE60005299T2 (en) | PREPARATION FOR WARTS | |
| DE3339474A1 (en) | Disposable sleeve shields | |
| DE3415155A1 (en) | Carrier body connected with microencapsulated liquids | |
| DE3033606A1 (en) | ANTI-ADHESIVE, ANTIMICROBIAL Wound Bandage AND METHOD FOR THE PRODUCTION THEREOF | |
| DE102008035848A1 (en) | Patch, useful e.g. for attaching to skin for medical, cosmetic and/or orthopedic purposes, and to treat capsule inflammations, comprises a film comprising a carrier material provided with a therapeutically effective coating on both sides | |
| DE2934090A1 (en) | Agent for treating hyper:keratotic skin diseases - contains undecylenic acid pref. in combination with ascorbic acid | |
| DE3114824A1 (en) | "USE OF A MEDICINE FOR THE TREATMENT OF PSORIASIS (psoriasis)" | |
| AT87642B (en) | Fur compress. | |
| DE297501C (en) | ||
| EP0566979A1 (en) | Hair lotion and hair treatment process for reducing hair loss and promoting hair growth | |
| DE959051C (en) | Menstrual aid | |
| DE225685C (en) | ||
| DE69211729T2 (en) | Use of a fabric in the manufacture of a cleaning, disinfecting or healing element | |
| DE202011106827U1 (en) | Nonwoven plaster for the prevention and healing of wound sites on the skin | |
| NAKANISHI | Vergleichende Beobachtung der mit lipidfärbenden Farbstoffen gefärbten Blutplättchen von verschiedenen Tieren | |
| Berencsi et al. | Über die Wirkungsweise von Streptomycin und Isonikotinsäurehydrazid anhand von Modellversuchen mit abgetöteten Tuberkelbazillen | |
| DE825129C (en) | Fixation bandage | |
| DE921711C (en) | Healing bandage with sprinkler device | |
| DE3447953A1 (en) | Pharmaceutical composition for treating the symptoms of pain associated with burns | |
| DE729116C (en) | Process for the production of sterile bandages or sterile catgut |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OAV | Applicant agreed to the publication of the unexamined application as to paragraph 31 lit. 2 z1 | ||
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8131 | Rejection |